Long-Term Efficacy and Adherence: The impact of novel oral formulations on sustained efficacy, weight maintenance, and patient compliance requires real-world assessment and comparative analyses
Donnelly M, Driever D, Ryan J, et al
Statistical Analyses A repeated measures general linear model was used to examine for differences in outcome measures between groups (1.5 g/d, 1 g/d, 4.5 g/d), conditions (pre- and post-GPLC) and across time
Phase 2 Clinical Trial Data The landmark Phase 2 trial of retatrutide in obesity was a 48-week, randomized, double-blind, placebo-controlled study published in The New England Journal of Medicine in 2023
By encouraging patients to stay active and make mindful dietary choices, they can experience faster weight loss and enhanced overall health